Hai-yan Wang, MD, 1937-2014
Min Chen,Ming-hui Zhao
DOI: https://doi.org/10.1053/j.ajkd.2015.02.317
IF: 11.072
2015-01-01
American Journal of Kidney Diseases
Abstract:On December 11, 2014, China and the world lost a distinguished clinician, scientist, and educator in nephrology, Professor Hai-yan Wang. The woman behind this internationally renowned name was enormously dedicated, enthusiastic, and of exceptional intelligence, and she became one of the key drivers of the development of modern nephrology in China. Hai-yan was born in Qingdao, in the Shandong Province of China, on July 8, 1937. After graduating from Beijing Medical College in 1959, she became a graduate student under Professor Shu-xian Wang, the founder of modern nephrology in China. Hai-yan received rigorous clinical and research training, and thereafter began the nephrology career that captured her lifelong devotion. In 1980, she was sponsored by the Chinese government to become a visiting scholar at the University of California at Los Angeles, under the supervision of Professor Richard J. Glassock. During her 3-year training in the United States, she undertook research projects and became the first Chinese nephrologist from mainland China to be selected for an oral presentation at the American Society of Nephrology annual meeting. In addition, she visited many successful renal programs in the United States and began to design a roadmap for bringing modern nephrology to China. Soon after she returned to China, Hai-yan took the position of Chief of the Renal Division at Peking University First Hospital. She spent 30 years building up a modern renal program in Beijing, with the goal, as described by Professor William G. Couser, head of the Global Outreach Programs of the International Society of Nephrology (ISN), being that "it could become…one of the top academic renal programs in the world (a goal now achieved, incidentally)."1Couser WG. Nephrology in China—a personal perspective. http://www.era-edta.org/images/NDTnewsletter_China6.pdf. Accessed February 3, 2015.Google Scholar Hai-yan, who in addition to being a tenured Professor of Medicine at Peking University First Hospital, was President of the Peking University Institute of Nephrology, made numerous contributions that established her as one the pioneers of modern nephrology in China. An early contribution to Chinese nephrology was Hai-yan's recognition of the etiologic heterogeneity of acute kidney injury (AKI) and her efforts in the 1980s to introduce a more nuanced understanding of primary glomerulonephritis. She was the very first to "transplant" the clinical and pathological conference system into a Chinese setting, introducing it to Peking University First Hospital. This helped Hai-yan expand the etiologic spectrum of AKI from acute tubular necrosis only to a variety of intrinsic kidney diseases such as acute interstitial nephritis and crescentic glomerulonephritis. She was also the first in China to report a variety of glomerular diseases of Chinese patients internationally and thus substantially improved treatment strategies. Before her passing, she had been leading and organizing the largest randomized controlled trial on IgA nephropathy, a global effort known as the TESTING Study. Another important contribution was her pioneering work in both experimental and clinical studies of kidney diseases in China. In the 1980s, she established many animal models of human glomerular diseases. She also initiated a tripartite model of research (ie, cellular, animal model, and human studies) for a series of research projects on traditional Chinese herbal medicines, such as identifying the renoprotective role of Astragalus mongholicus combined with Angelica sinensis, and defining the nephrotoxic and profibrotic effects of aristolochic acid–containing herbs. Over a period of 30 years, she set up clinical databases and bio-banks for a number of kidney diseases, which contributed greatly to subsequent translational studies. These strategies helped guide nephrology research in China. Hai-yan was also responsible for the launch of Chinese clinical epidemiology related to chronic kidney disease (CKD) and AKI. Her team established a glomerular filtration rate estimation equation suitable for use in Chinese populations.2Ma Y.C. Zuo L. Chen J.H. et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.J Am Soc Nephrol. 2006; 17: 2937-2944Crossref PubMed Scopus (1558) Google Scholar She organized a national epidemiological survey3Zhang L. Zuo L. Wang F. et al.Cardiovascular disease in early stages of chronic kidney disease in a Chinese population.J Am Soc Nephrol. 2006; 17: 2617-2621Crossref PubMed Scopus (39) Google Scholar and established the first CKD cohort (C-STRIDE)4Gao B. Zhang L. Wang H. Zhao M. Chinese cohort study of chronic kidney disease: design and methods.Chin Med J (Engl). 2014; 127: 2180-2185PubMed Google Scholar to reveal the prevalence and risk factors of chronic kidney diseases in China. These achievements not only gained international recognition and attention, but also led to a proposed prevention and treatment strategy for CKD in China.5Zhang L. Wang F. Wang L. et al.Prevalence of chronic kidney disease in China: a cross-sectional survey.Lancet. 2012; 379: 815-822Abstract Full Text Full Text PDF PubMed Scopus (1715) Google Scholar Alongside her many research advances, Hai-yan also contributed greatly to medical education. As an outstanding physician-scientist, she not only established a first-rate renal program at Peking University First Hospital, but also trained many nephrologists throughout the country, which greatly improved nephrology in China. In 2013, for her outstanding contributions to nephrology education and the development of modern nephrology in China, Hai-yan was named as a recipient of the ISN's Roscoe R. Robinson Award and was among the first ISN Pioneers in Nephrology awardees. The letter from Professors John Feehally (ISN President) and Couser conferring the latter award detailed her many accomplishments:Hai-yan, your selection for this honor by the society reflects our recognition of your well-deserved identity as the "mother of Chinese nephrology." ISN honors you for your pioneering leadership in the development of nephrology in China from the 1960s to the present. You have served as a consistent role model of the renal physician-scientist despite challenging personal and political circumstances, and have effectively drawn on resources from around the developed world to create a modern clinical, research, and educational program at Peking University First Hospital that not only elevates the standard of nephrology in your country but serves as a model for the rest of the developing world. Hai-yan was very active in national and international organizations relating to nephrology and internal medicine. She was an ISN Council member (2004-2008), ISN Executive Councilor (2006-2008), Chair of the ISN Global Outreach East Asia subcommittee (2004-2013), and a member of the ISN advisory group for the "0 by 25" AKI initiative. In addition, she served as Vice President of the Chinese Medical Association (1999-2009), President of the Chinese Society of Internal Medicine (2000-2008), and President of the Chinese Society of Nephrology (1992-1998). Hai-yan Wang's name will forever be linked to the development of nephrology in China, and her legacy will continue to shape the field in China and worldwide.